Skip to main content
SpringerLink
Log in

Biologic drugs may have extended market exclusivity from generic competition for up to 12 years

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Taylor L.US House panel backs 12 years' protection for biologic drugs. Pharma Times: [2 pages], 3 Aug 2009. Available from: URL: http://www.pharmatimes.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biologic drugs may have extended market exclusivity from generic competition for up to 12 years. Pharmacoecon. Outcomes News 584, 10 (2009). https://doi.org/10.2165/00151234-200905840-00025

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905840-00025

Keywords

Search

Navigation